¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Dyskinesia of oesophagus"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • biliary dyskinesia
    ¾µ°³°ü¿îµ¿ÀÌ»ó(Áõ), ´ã°ü¿îµ¿ÀÌ»ó(Áõ)
  • dyskinesia
    1. ¿îµ¿ÀÌ»ó(Áõ) 2. ÀÌ»ó¿îµ¿(Áõ)
  • extrapyramidal dyskinesia
    ÇǶó¹Ìµå¹Ù±ù±æÀÌ»ó¿îµ¿Áõ, Ãßü¿Ü·ÎÀÌ»ó¿îµ¿Áõ
  • primary ciliary dyskinesia
    ¿ø¹ß¼¶¸ð¿îµ¿ÀÌ»óÁõ
  • tardive dyskinesia
    Áö¿¬¼ºÀÌ»ó¿îµ¿(Áõ)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dyskinesia
    ¿îµ¿ÀÌ»óÁõ
  • tardive dyskinesia
    Áö¿¬¹ß»ý¿îµ¿ÀÌ»óÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • biliary dyskinesia
    ¾µ°³°ü¿îµ¿ÀÌ»óÁõ
  • dyskinesia
    ¿îµ¿ÀÌ»óÁõ
  • primary ciliary dyskinesia
    ¿ø¹ß¼¶¸ð¿îµ¿ÀÌ»óÁõ
  • tardive dyskinesia
    Áö¿¬¿îµ¿ÀÌ»óÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dyskinesia, tardive (tardive dyskinesia)
    Áö¹ß¼º ¿îµ¿Àå¾Ö.
  • oesophagus =esophagus ³ª
    ½Äµµ(ãÝÔ³).
  • biliary dyskinesia
    ´ãµµ¿îµ¿ÀåÇØ
  • biliary dyskinesia
    ´ãµµÀÌ»ó¿îµ¿Áõ.
  • biliary dyskinesia
    ´ãµµ ÀÌ»ó¿îµ¿Áõ.
  • ciliary dyskinesia
    ¼¶¸ð ÀÌ»ó¿îµ¿Áõ(àéÙ¾ì¶ßÈê¡ÔÑñø)
  • dyskinesia
    ÀÌ»ó¿îµ¿Áõ(ì¶ßÈê¡ÔÑñø).
  • dyskinesia
    ¿îµ¿ °ï¶õ(Áõ)
  • dyskinesia,biliary
    ´ãµµ¿îµ¿ÀÌ»óÁõ
  • primary ciliary dyskinesia
  • respiratory dyskinesia
    È£Èí¼º ¿îµ¿°ï¶õÁõ
  • tardive dyskinesia
    Áö¿¬¼º ¿îµ¿Àå¾Ö(òÀæÅàõê¡ÔÑî¡äô)(º´).
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dyskinesia
    ÀÌ»ó¿îµ¿Áõ
  • oesophagus
    ½Äµµ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
oesoph esophagus [oesophagus]
BLFD buccolinguofacial dyskinesia
CDA Canadian Dental Association; Certified Dental Assistant; chenodeoxycholic acid; ciliary dyskinesia a...
DRS descending rectal septum; diagnostic review station; Division of Research Services [NIH]; drowsiness...
ID identification; iditol dehydrogenase; immunodeficiency; immunodiffusion; immunoglobulin deficiency; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
LID Levodopa-induced dyskinesia
PCD Primary Ciliary Dyskinesia
TD Tardive Dyskinesia
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • K22.4
    Dyskinesia of oesophagus
    ½ÄµµÀÇ ¼öÀǿÀå¾Ö
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dyskinesia intermittens
    °£Ç漺 ¿îµ¿ ºÎÀü
    ¼øÈ¯ Àå¾Ö¿¡ ÀÇÇÏ¿© ÀϾ¸ç °£ÇæÀûÀ¸·Î »çÁöÀÇ ¹«·ÂÀÌ ³ªÅ¸³­´Ù.
  • masticatory muscle dyskinesia
    ÀúÀÛ±Ù ºÎÁ¶È­, ÀúÀÛ±Ù ÀÌ»ó ¿îµ¿Áõ
  • oral dyskinesia
    ±¸°­ ¿îµ¿ ÀÌ»ó
  • orofacial dyskinesia
    ±¸°­ ¾È¸é ¿îµ¿ Àå¾Ö, ±¸°­ ¾È¸é ¿îµ¿ ºÎÁ¶È­, ±¸°­ ¾È¸é ¿îµ¿ ÀÌ»ó
  • tardive dyskinesia
    Áö¹ß¼º ¿îµ¿ Àå¾Ö
    µ¿ÀǾî=tardive dyskinesia.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anti-dyskinesia agents Drugs used in the treatment of movement disorders. most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of parkinson disease (antiparkinson agents) and those for the tardive dyskinesias.
(12 Dec 1998)
biliary dyskinesia Structural or functional abnormality of the sphincter of Oddi that interferes with bile drainage.
Synonym: biliary dyskinesia.
(05 Mar 2000)
dyskinesia <neurology> The impairment of the power of voluntary movement, resulting in fragmentary or incomplete movements.
Origin: Gr. Dyskinesia = difficulty of moving
(18 Nov 1997)
dyskinesia algera A hysterical condition in which active movement causes pain.
(05 Mar 2000)
dyskinesia, drug-induced Abnormal movements induced as an adverse reaction of drug therapy. One particular movement disorder is the "on-off" effect. Tardive dyskinesia differs from akathisia, drug-induced in the repetitive nature of the movements rather than being associated with anxiety, restlessness, and agitation found in akathisia.
(12 Dec 1998)
dyskinesia intermittens Intermittent disability of the limbs due to impairment of circulation.
(05 Mar 2000)
tardive dyskinesia A syndrome of potentially irreversible, involuntary, dyskinetic movements that may develop in patients who have been treated with antipsychotic medications (for example phenothiazines) longer-term. Other drugs known to cause tardive dyskinesia include: tricyclic antidepressants, selegiline, clozapine, levamisole and metoclopramide.
(27 Sep 1997)
tracheobronchial dyskinesia Degeneration of elastic and connective tissue of bronchi and trachea.
(05 Mar 2000)
lingual-facial-buccal dyskinesia A syndrome of potentially irreversible, involuntary, dyskinetic movements that may develop in patients who have been treated with antipsychotic medications (for example phenothiazines) longer-term. Other drugs known to cause tardive dyskinesia include: tricyclic antidepressants, selegiline, clozapine, levamisole and metoclopramide.
(27 Sep 1997)
abdominal part of oesophagus The part of the oesophagus inferior to the diaphragm.
See: oesophagus.
Synonym: pars abdominalis oesophagi.
(05 Mar 2000)
adenocarcinoma in Barrett's oesophagus An adenocarcinoma arising in the lower third of the oesophagus that has become columnar cell lined (Barrett's mucosa) due to gastroesophageal reflux.
(05 Mar 2000)
barrett oesophagus <radiology> Replacement of squamous epithelium with columnar metaplasia in lower oesophagus, incidence: 2-10% of patients with reflux oesophagitis, associated with adenocarcinoma in 8-10% findings: large deep ulceration with or without stricture at distal/mid oesophagus, fine reticular pattern, commonly reflux, columnar epithelium secretes Tc-99m pertechnetate
(12 Dec 1998)
barrett's oesophagus A disorder in which the lining of the oesophagus undergoes cellular changes in response to chronic irritation and inflammation of reflux oesophagitis. This condition is more common in men than women. The patient with Barrett's oesophagus is at an increased risk of developing cancer of the oesophagus.
Symptoms are similar to those of reflux oesophagitis and include heartburn, difficulty swallowing and pain relief with antiacid use or eating. The diagnosis of Barrett's is made by a biopsy of the oesophageal mucosa through a endoscope.
Treatment includes control of reflux disease, weight reduction and avoidance of alcohol, tobacco, fatty foods and lying flat after eating. Close follow-up is recommended to be certain the individual does not develop cancer of the oesophagus.
(27 Sep 1997)
bullous diseases of oesophagus <radiology> Epidermolysis bullosa dystrophica, autosomal recessive, presents in infancy or later life, epidermal-dermal separation, with or without anal strictures, Treatment: conservative, soft diet, benign mucous membrane (cicatricial) pemphigoid, not pemphigus vulgaris, not bullous pemphigoid, females (2:1), elderly
(12 Dec 1998)
cancer, oesophagus Cancer of the swallowing tube that passes from the throat to the stomach. The risk of cancer of the oesophagus is increased by long-term irritation of the oesophagus, such as with smoking, heavy alcohol intake, and Barrett's oesophagitis. Cancer of the oesophagus can cause difficulty and pain with swallowing solid food. Diagnosis of oesophageal cancer can be made by barium X-ray of the oesophagus, and confirmed by endoscopy with biopsy of the cancer tissue.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oesophagus
    =Esophagus
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á